The Evolving Treatment Options for Diabetic Macular Edema
Joint Authors
Varshney, Neeta
Smith, Colin
Jain, Atul
Source
International Journal of Inflammation
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-09-09
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Diabetic retinopathy (DR) is the leading cause of vision loss in working-age adults, and diabetic macular edema (DME) is the most common cause of visual impairment in individuals with DR.
This review focuses on the pathophysiology, previous treatment paradigms, and emerging treatment options in the management of DME.
American Psychological Association (APA)
Jain, Atul& Varshney, Neeta& Smith, Colin. 2013. The Evolving Treatment Options for Diabetic Macular Edema. International Journal of Inflammation،Vol. 2013, no. 2013, pp.1-10.
https://search.emarefa.net/detail/BIM-490711
Modern Language Association (MLA)
Jain, Atul…[et al.]. The Evolving Treatment Options for Diabetic Macular Edema. International Journal of Inflammation No. 2013 (2013), pp.1-10.
https://search.emarefa.net/detail/BIM-490711
American Medical Association (AMA)
Jain, Atul& Varshney, Neeta& Smith, Colin. The Evolving Treatment Options for Diabetic Macular Edema. International Journal of Inflammation. 2013. Vol. 2013, no. 2013, pp.1-10.
https://search.emarefa.net/detail/BIM-490711
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-490711
